We engineer proteins for next-generation immunotherapies

In the Yamada-Hunter Lab, we use protein engineering and synthetic biology to develop next-generation therapeutics tackling diseases ranging from cancer to autoimmunity and beyond. Our research sits at the intersection of immunology, bioengineering, and cancer biology, performing translational research to create a suite of engineered immunotherapies, with a focus on combination therapy and ultimately clinical development.

Illustration credit: Gerardo Sotillo